רילרט 80 מג
pfizer pfe pharmaceuticals israel ltd - eletriptan hydrobromide - טבליות מצופות פילם - eletriptan hydrobromide 96.97 mg - eletriptan
פלוניקסין תמיסה להזרקה קומקס וטרינרי
comex ltd - flunixin as meglumine - תמיסה להזרקה - flunixin as meglumine 50 mg/ml
קולוטאל טבליות 135 מג
padagis israel pharmaceuticals ltd, israel - mebeverine hydrochloride - טבליה - mebeverine hydrochloride 135 mg - mebeverine - mebeverine - irritable bowel syndrome and conditions included in this group such as: chronic irritable colon, gastro- intestinal spasm secondary to organic diseases
סיברי בריזהלר 50 מק"ג
novartis pharma services ag - glycopyrronium bromide 63 mcg - inhalation powder hard capsules - glycopyrronium - maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (copd).
רזולור 1 מג
biotis ltd - prucalopride as succinate - טבליות מצופות פילם - prucalopride as succinate 1 mg - prucalopride - prucalopride - resolor is indicated for symptomatic treatment of chronic constipation in women in whom laxatives fail to provide adequate relief
רזולור 2 מג
biotis ltd - prucalopride as succinate - טבליות מצופות פילם - prucalopride as succinate 2 mg - prucalopride - prucalopride - resolor is indicated for symptomatic treatment of chronic constipation in women in whom laxatives fail to provide adequate relief
אורסוליט 100
cts chemical industries ltd, israel - ursodeoxycholic acid - טבליה - ursodeoxycholic acid 100 mg - ursodeoxycholic acid - ursodeoxycholic acid - dissolution or reductin in size of radiolucent cholesterol in patient with a functioning gallbladder. treatment of chronic liver diseases including primary billiary cirrhosis, primary sclerosing cholangitis, cystic fibrosis associated liver disease, biliary atresia, chronic hepatitis, and alcohol cirrhosis.
אורסוליט 300
cts chemical industries ltd, israel - ursodeoxycholic acid - טבליה - ursodeoxycholic acid 300 mg - ursodeoxycholic acid - ursodeoxycholic acid - dissolution or reduction in size of radiolucent cholesterol gallstones in patients with a functioning gallbladder. treatment of chronic liver diseases including primary biliary cirrhosis, primary sclerosing cholangitis, cystic fibrosis associated liver disease, biliary atresia chronic hepatitis and alcoholic cirrhosis.
אורסופאלק תרחיף
rafa laboratories ltd - ursodeoxycholic acid 250 mg / 5 ml - suspension - ursodeoxycholic acid - dissolution or reduction in size of radiolucent cholesterol gallstones. treatment of certain chronic liver diseases.
אורסופאלק כמוסות 250
rafa laboratories ltd - ursodeoxycholic acid - קפסולות - ursodeoxycholic acid 250 mg - ursodeoxycholic acid - ursodeoxycholic acid - treatment of chronic liver diseases primary biliary cirrhosis & primary sclerosing cholangitis.